Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoRecormon for Anemia in Chronic Hepatitis C Treatment
NCT00262379Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Dec 2005
- Primary completion
- Jun 2009
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin beta in hepatitis C (HCV), sponsored by Centre Hospitalier Universitaire d'Angers. Started Dec 2005; status: completed.
02
Drugs
epoetin beta
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00262379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262379.